Literature DB >> 9436748

Paraneoplastic opsoclonus associated with papillary renal cell carcinoma.

A Koukoulis, I Cimas, S Gómara.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9436748      PMCID： PMC2169897          DOI： 10.1136/jnnp.64.1.137

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Paraneoplastic Opsoclonus-Myoclonus Syndrome: initial presentation of non-Hodgkins lymphoma.

Authors:  Ashwani Kumar; Walter A Lajara-Nanson; Robert W Neilson
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

2.  Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review.

Authors:  Macarena Villagrán-García; Sergio Muñiz-Castrillo; Nicolás Lundahl Ciano-Petersen; Alberto Vogrig; Antonio Farina; Marine Villard; Dimitri Psimaras; Agusti Alentorn; David Gonçalves; Nicole Fabien; Véronique Rogemond; Bastien Joubert; Jérôme Honnorat
Journal:  J Neurol       Date:  2022-09-01       Impact factor: 6.682

Review 3.  Long Non-Coding RNAs as Novel Biomarkers in the Clinical Management of Papillary Renal Cell Carcinoma Patients: A Promise or a Pledge?

Authors:  Francesco Trevisani; Matteo Floris; Riccardo Vago; Roberto Minnei; Alessandra Cinque
Journal:  Cells       Date:  2022-05-17       Impact factor: 7.666

4.  Paraneoplastic Peripheral Nervous System Manifestations of Renal Cell Carcinoma: A Case Report and Review of the Literature.

Authors:  Ingrid Yang; Joanna Jaros; Danny Bega
Journal:  Case Rep Neurol       Date:  2017-02-20

5.  Acanthosis Nigricans associated with clear-cell renal cell carcinoma.

Authors:  Fernando Peixoto Ferraz de Campos; Margarita Rosa Aveiga Narvaez; Paola Vasconcellos Soares Reis; Augusto Cesar Marins Gomes; Daniela Kallíope de Sá Paraskevopoulos; Frederico Santana; Oscar Eduardo Hidetoshi Fugita
Journal:  Autops Case Rep       Date:  2016-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.